Sonnet BioTherapeutics Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IFP ADVISORS, INC | 11/08/2022 | 2,000 | $13,000 | 0.00% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 11/15/2022 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/10/2022 | 0 | $0 | -100.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/10/2022 | 0 | $0 | -100.00% | 0.00% |
| MAIN STREET FINANCIAL SOLUTIONS, LLC | 10/24/2022 | 0 | $0 | -100.00% | 0.00% |
| CAMPION ASSET MANAGEMENT | 11/10/2022 | 0 | $0 | -100.00% | 0.00% |
| RATIO WEALTH GROUP | 03/27/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sonnet BioTherapeutics Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 1 institutional investors and hedge funds held shares of Sonnet BioTherapeutics Holdings, Inc.. The most heavily invested institutionals were:
Carroll Financial Associates, Inc.: 10
0.05% of Sonnet BioTherapeutics Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10 shares in the last 24 months. This purchase volume represents approximately $19 in transactions.